Rayence Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 2/6

Rayence yıllık ortalama 18.6% oranında kazançlarını artırırken, Medical Equipment sektöründe kazançlar growing at 16.7% annual. Gelirler growing yılda ortalama 5.6% oranında artmaktadır. Rayence'in özkaynak karlılığı 7.1% ve net marjı 12.9%'dir.

Anahtar bilgiler

18.6%

Kazanç büyüme oranı

18.6%

EPS büyüme oranı

Medical Equipment Sektör Büyümesi	22.7%
Gelir büyüme oranı	5.6%
Özkaynak getirisi	7.1%
Net Marj	12.9%
Son Kazanç Güncellemesi	30 Jun 2024

Yakın geçmiş performans güncellemeleri

Rayence's (KOSDAQ:228850) Profits May Not Reveal Underlying Issues

May 25

Are Rayence's (KOSDAQ:228850) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Feb 02

Recent updates

Rayence Co., Ltd. (KOSDAQ:228850) Is Up But Financials Look Inconsistent: Which Way Is The Stock Headed?

Mar 05

Will Rayence (KOSDAQ:228850) Multiply In Value Going Forward?

Feb 17

Are Rayence's (KOSDAQ:228850) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Feb 02

Rayence's(KOSDAQ:228850) Share Price Is Down 44% Over The Past Three Years.

Jan 18

Should Rayence Co., Ltd. (KOSDAQ:228850) Be Part Of Your Dividend Portfolio?

Jan 06

Income Investors Should Know That Rayence Co., Ltd. (KOSDAQ:228850) Goes Ex-Dividend Soon

Dec 25

At ₩11,100, Is It Time To Put Rayence Co., Ltd. (KOSDAQ:228850) On Your Watch List?

Dec 14

Rayence (KOSDAQ:228850) Seems To Use Debt Quite Sensibly

Dec 01

A Look At The Intrinsic Value Of Rayence Co., Ltd. (KOSDAQ:228850)

Nov 18

Gelir ve Gider Dağılımı

Rayence nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.

Kazanç ve Gelir Geçmişi

KOSDAQ:A228850 Gelir, gider ve kazançlar (KRW Millions )
Tarih	Gelir	Kazançlar	G+A Giderleri	Ar-Ge Giderleri
30 Jun 24	136,322	17,558	25,413	13,132
31 Mar 24	141,121	20,963	25,053	11,452
31 Dec 23	142,986	19,600	25,421	10,795
30 Sep 23	145,736	21,118	26,438	10,805
30 Jun 23	148,751	19,975	26,285	10,354
31 Mar 23	148,640	19,932	26,452	10,103
31 Dec 22	147,161	22,049	26,035	9,326
30 Sep 22	146,257	21,570	24,131	8,660
30 Jun 22	140,174	18,239	23,656	8,619
31 Mar 22	139,207	13,087	21,971	8,411
31 Dec 21	134,568	14,458	20,253	8,171
30 Sep 21	129,291	4,328	19,876	7,593
30 Jun 21	119,423	552	19,808	6,517
31 Mar 21	105,745	-25	19,723	5,552
31 Dec 20	101,524	-1,916	21,337	4,785
30 Sep 20	106,506	4,466	21,352	4,189
30 Jun 20	115,408	9,992	21,622	3,895
31 Mar 20	125,120	14,398	22,960	4,186
31 Dec 19	126,175	14,688	22,261	3,898
30 Sep 19	120,608	16,018	22,192	4,277
30 Jun 19	118,165	15,282	21,281	4,374
31 Mar 19	116,220	16,006	20,013	4,147
31 Dec 18	116,389	15,728	19,336	4,298
30 Sep 18	114,811	18,597	17,765	3,760
30 Jun 18	114,491	18,433	18,110	3,716
31 Mar 18	110,391	16,389	18,460	3,720
31 Dec 17	106,518	14,622	18,689	3,589
30 Sep 17	108,483	15,477	20,098	3,872
30 Jun 17	102,915	14,723	19,237	3,783
31 Mar 17	100,789	14,598	18,553	3,936
31 Dec 16	98,457	14,745	17,316	4,054
30 Sep 16	93,980	14,072	15,192	3,791
30 Jun 16	92,467	14,984	14,842	3,754
31 Mar 16	88,681	14,513	14,364	3,650
31 Dec 15	86,609	14,482	13,697	3,360
31 Dec 14	77,943	3,217	13,068	5,499
31 Dec 13	69,183	3,183	12,702	5,233

Kaliteli Kazançlar: A228850 yüksek kaliteli kazançlar sağlıyor.

Büyüyen Kar Marjı: A228850 'nin mevcut net kar marjları (12.9%) geçen yılın (13.4%) değerinden daha düşüktür.

Serbest Nakit Akışı ve Kazanç Analizi

Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: A228850 şirketinin kazancı son 5 yılda yılda 18.6% oranında arttı.

Büyüme Hızlandırma: A228850 'in son bir yıldır negatif kazanç büyümesi oldu, bu nedenle 5 yıllık ortalamasıyla karşılaştırılamaz.

Kazançlar vs. Sektör: A228850 geçtiğimiz yıl negatif kazanç büyümesine ( -12.1% ) sahipti ve bu da onu Medical Equipment sektör ortalamasıyla ( 4% ) karşılaştırmayı zorlaştırıyordu.

Özkaynak Getirisi

Yüksek ROE: A228850 'nin Özsermaye Getirisi ( 7.1% ) düşük olarak değerlendiriliyor.

Rayence Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 2/6

Anahtar bilgiler

Yakın geçmiş performans güncellemeleri

Second quarter 2024 earnings released: EPS: ₩178 (vs ₩394 in 2Q 2023)

Rayence's (KOSDAQ:228850) Profits May Not Reveal Underlying Issues

Full year 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Full year 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Full year 2020 earnings released: ₩122 loss per share (vs ₩933 profit in FY 2019)

Are Rayence's (KOSDAQ:228850) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Recent updates

Second quarter 2024 earnings released: EPS: ₩178 (vs ₩394 in 2Q 2023)

New major risk - Revenue and earnings growth

Consensus EPS estimates fall by 19%

Lacklustre Performance Is Driving Rayence Co., Ltd.'s (KOSDAQ:228850) Low P/E

Rayence Co., Ltd. (KOSDAQ:A228850) agreed to acquire additional 11.55% stake in Woorien Co., Ltd. from Murex Search No.1 Fund managed by Murex Partners LLC for KRW 12.5 billion.

Rayence Co., Ltd. (KOSDAQ:A228850) agreed to acquire additional 11.55% stake in Woorien Co., Ltd. from Murex Search No.1 Fund managed by Murex Partners LLC for KRW 12.5 billion.

Rayence's (KOSDAQ:228850) Profits May Not Reveal Underlying Issues

Consensus EPS estimates fall by 21%

New minor risk - Market cap size

Full year 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Upcoming dividend of ₩300 per share at 3.2% yield

Price target decreased by 13% to ₩13,000

Full year 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Upcoming dividend of ₩100.00 per share

Price target decreased to ₩14,500

Price target decreased to ₩16,500

Price target decreased to ₩17,500

Upcoming dividend of ₩100.00 per share

Rayence Launches 3D Inline AXI Detector, MIDAS 2121

Price target increased to ₩17,500

We Think Rayence (KOSDAQ:228850) Can Stay On Top Of Its Debt

Full year 2020 earnings released: ₩122 loss per share (vs ₩933 profit in FY 2019)

Rayence Co., Ltd. (KOSDAQ:228850) Is Up But Financials Look Inconsistent: Which Way Is The Stock Headed?

New 90-day high: ₩12,150

Will Rayence (KOSDAQ:228850) Multiply In Value Going Forward?

Are Rayence's (KOSDAQ:228850) Statutory Earnings A Good Reflection Of Its Earnings Potential?

New 90-day high: ₩11,900

Rayence's(KOSDAQ:228850) Share Price Is Down 44% Over The Past Three Years.

Should Rayence Co., Ltd. (KOSDAQ:228850) Be Part Of Your Dividend Portfolio?

Income Investors Should Know That Rayence Co., Ltd. (KOSDAQ:228850) Goes Ex-Dividend Soon

Upcoming Dividend of ₩300 Per Share

At ₩11,100, Is It Time To Put Rayence Co., Ltd. (KOSDAQ:228850) On Your Watch List?

Rayence (KOSDAQ:228850) Seems To Use Debt Quite Sensibly

A Look At The Intrinsic Value Of Rayence Co., Ltd. (KOSDAQ:228850)

Analysts lower EPS estimates to ₩604

New 90-day low: ₩10,650

Analysts lower EPS estimates to ₩788

New 90-day low - ₩10,800

Analysts lower EPS estimates to ₩920

Gelir ve Gider Dağılımı

Kazanç ve Gelir Geçmişi

Serbest Nakit Akışı ve Kazanç Analizi

Geçmiş Kazanç Büyüme Analizi

Özkaynak Getirisi

Varlık Getirisi

Kullanılan Sermaye Getirisi

Geçmişte güçlü performans gösteren şirketleri keşfedin